Christine Brown, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 15 years
- Graduated 2011
Offices
1 location · One Medical Group Inc · 330 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Christine Brown’s office at (888) 663-6331 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G57680 · Cancelled
Licence status: Cancelled · since 1986 · George Washington University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$4,614
Medicare paid this office $4,614 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 12 | $709 | $55 |
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 71 · Also on Medicaid 0% · Health risk score 0.84. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
The office billed $39,113, Medicare allowed $6,636 and paid $4,614; for 70 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 21 | 70 | 71 | 0.84 | $39,113 | $4,614 |
| 2023 | 27 | 81 | 73 | 0.84 | $42,497 | $6,069 |
| 2022 | 42 | 61 | 71 | 0.76 | $31,500 | $4,435 |
| 2021 | 15 | 20 | 71 | 0.63 | $9,120 | $1,154 |
| 2020 | 29 | 52 | 70 | 0.71 | $12,113 | $1,726 |
| 2019 | 128 | 286 | 74 | 1.08 | $36,238 | $12,502 |
| 2018 | 17 | 28 | 66 | 1.23 | $4,784 | $1,324 |
| 2017 | 23 | 45 | 73 | 1.13 | $5,948 | $1,738 |
| 2015 | 66 | 113 | 73 | 1.44 | $17,420 | $5,443 |
| 2014 | 50 | 128 | 70 | 1.19 | $16,503 | $5,541 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 12 | $2,142 | $102 |
2022: 1 service
| Short return visit (20+ min) | 25 | $1,731 | $69 |
2019: 6 services
| Return visit (30+ min) | 80 | $5,855 | $61 |
| New patient visit (45+ min) | 18 | $1,689 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,062 | $97 |
| Short return visit (20+ min) | 19 | $935 | $45 |
| Injection of drug or substance under skin or into muscle | 11 | $188 | $10 |
| Manual urinalysis test with examination using microscope, non-automated | 14 | $59 | $4 |
2015: 2 services
| Return visit (30+ min) | 45 | $3,537 | $67 |
| Short return visit (20+ min) | 17 | $824 | $46 |
2014: 2 services
| Return visit (30+ min) | 39 | $3,550 | $70 |
| Short return visit (20+ min) | 20 | $1,257 | $48 |
Medicaid work
$2,808 in 2020
Medicaid paid $2,808 for 34 billed services this clinician did in 2020, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 34 | $2,808 |
| 2020 | 34 | 1 | 18 | $2,808 |
Drugs they prescribed that Part D paid
$4,967
Pharmacies billed $4,967 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
93 generic and 17 brand-name prescriptions · $4,967 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 110 | 33 | None | 15% | $4,967 |
| 2023 | 112 | 28 | None | None | $6,278 |
| 2022 | 137 | 29 | 0% (0) | None | $13,043 |
| 2021 | 70 | 25 | 0% (0) | None | $5,613 |
| 2020 | 624 | 201 | 0% (0) | None | $50,614 |
| 2019 | 2,615 | 344 | None | 15% | $216,061 |
| 2018 | 2,373 | 319 | None | 19% | $212,311 |
| 2017 | 2,862 | 351 | 1% (30) | 18% | $224,370 |
| 2016 | 2,418 | 333 | 2% (44) | 22% | $208,003 |
| 2015 | 1,973 | 322 | 1% (20) | None | $164,435 |
| 2014 | 1,585 | 269 | 1% (18) | None | $118,527 |
| 2013 | 939 | 212 | 2% (20) | None | $64,604 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Lisinopril | 15 | $138 | $9 |
2020: 13 drugs
| Metoprolol | 26 | $1,042 | $40 |
| Levothyroxine | 34 | $934 | $27 |
| Atorvastatin | 46 | $587 | $13 |
| Omeprazole | 22 | $405 | $18 |
| Potassium Chloride | 11 | $394 | $36 |
| Lisinopril | 38 | $335 | $9 |
| Losartan | 24 | $249 | $10 |
| Fluticasone Propionate | 11 | $181 | $16 |
| Metformin | 24 | $145 | $6 |
| Metformin Hcl Er | 15 | $144 | $10 |
| Carvedilol | 16 | $113 | $7 |
| Amlodipine Besylate | 15 | $112 | $7 |
| Alendronate | 12 | $80 | $7 |
2019: 53 drugs
| Januvia | 25 | $24,897 | $996 |
| Xarelto | 23 | $24,480 | $1,064 |
| Trulicity | 14 | $14,277 | $1,020 |
| Metoprolol | 90 | $4,100 | $46 |
| Levothyroxine | 149 | $3,791 | $25 |
| Raloxifene | 21 | $3,540 | $169 |
| Atorvastatin | 214 | $2,995 | $14 |
| Fenofibrate | 32 | $2,305 | $72 |
| Ventolin Hfa | 15 | $1,327 | $88 |
| Omeprazole | 68 | $1,195 | $18 |
| Esomeprazole Magnesium | 24 | $1,187 | $49 |
| Metformin | 119 | $1,170 | $10 |
| Synthroid | 13 | $1,122 | $86 |
| Lisinopril | 142 | $1,087 | $8 |
| Gabapentin | 38 | $939 | $25 |
| Olmesartan Medoxomil | 15 | $914 | $61 |
| Ultra-Fine Nano Pen Needle | 11 | $912 | $83 |
| Rosuvastatin | 49 | $833 | $17 |
| Losartan | 75 | $818 | $11 |
| Metformin Hcl Er | 65 | $754 | $12 |
| Ibandronate | 11 | $722 | $66 |
| Montelukast | 31 | $720 | $23 |
| Alendronate | 72 | $673 | $9 |
| Fluticasone Propionate | 45 | $646 | $14 |
| Pravastatin | 20 | $645 | $32 |
| Potassium Chloride | 22 | $627 | $28 |
| Amlodipine Besylate | 69 | $608 | $9 |
| Pioglitazone | 23 | $531 | $23 |
| Simvastatin | 56 | $468 | $8 |
| Glimepiride | 38 | $443 | $12 |
| Trazodone | 20 | $419 | $21 |
| Diclofenac | 12 | $409 | $34 |
| Lovastatin | 19 | $399 | $21 |
| Metoprolol | 27 | $351 | $13 |
| Carvedilol | 33 | $338 | $10 |
| Hydrochlorothiazide | 42 | $333 | $8 |
| Pantoprazole | 20 | $333 | $17 |
| Allopurinol | 15 | $305 | $20 |
| Escitalopram | 15 | $292 | $19 |
| Citalopram Hbr | 23 | $291 | $13 |
| Fluoxetine | 15 | $271 | $18 |
| Sertraline | 25 | $259 | $10 |
| Ranitidine | 13 | $250 | $19 |
| Clopidogrel | 17 | $228 | $13 |
| Furosemide | 24 | $195 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $172 | $14 |
| Sumatriptan | 16 | $138 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $130 | $9 |
| Ciprofloxacin | 17 | $127 | $7 |
| Benazepril | 15 | $123 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $75 | $4 |
| Clonidine | 16 | $60 | $4 |
| Prednisone | 14 | $49 | $3 |
2018: 46 drugs
| Januvia | 24 | $14,199 | $592 |
| Xarelto | 15 | $13,034 | $869 |
| Lantus Solostar | 15 | $7,039 | $469 |
| Atorvastatin | 147 | $3,270 | $22 |
| Levothyroxine | 122 | $3,099 | $25 |
| Proair Hfa | 19 | $2,869 | $151 |
| Metoprolol | 46 | $2,713 | $59 |
| Raloxifene | 14 | $2,627 | $188 |
| Fenofibrate | 29 | $2,064 | $71 |
| Rosuvastatin | 41 | $1,782 | $43 |
| Metformin | 105 | $1,139 | $11 |
| Omeprazole | 55 | $1,071 | $19 |
| Doxycycline Monohydrate | 15 | $1,055 | $70 |
| Synthroid | 18 | $1,046 | $58 |
| Lisinopril | 128 | $946 | $7 |
| Simvastatin | 97 | $943 | $10 |
| Pravastatin | 25 | $930 | $37 |
| Lovastatin | 48 | $872 | $18 |
| Gabapentin | 46 | $854 | $19 |
| Montelukast | 29 | $846 | $29 |
| Citalopram Hbr | 30 | $798 | $27 |
| Losartan | 64 | $709 | $11 |
| Fluticasone Propionate | 26 | $642 | $25 |
| Amlodipine Besylate | 71 | $638 | $9 |
| Alendronate | 41 | $628 | $15 |
| Potassium Chloride | 15 | $595 | $40 |
| Ranitidine | 23 | $588 | $26 |
| Trazodone | 27 | $559 | $21 |
| Glipizide Er | 17 | $554 | $33 |
| Warfarin | 18 | $474 | $26 |
| Carvedilol | 29 | $467 | $16 |
| Pantoprazole | 16 | $430 | $27 |
| Fluoxetine | 21 | $412 | $20 |
| Nitrofurantoin Mono-Macro | 12 | $395 | $33 |
| Oxybutynin Chloride | 14 | $395 | $28 |
| Pioglitazone | 18 | $371 | $21 |
| Hydrochlorothiazide | 32 | $356 | $11 |
| Metformin Hcl Er | 41 | $346 | $8 |
| Glimepiride | 19 | $342 | $18 |
| Clopidogrel | 15 | $303 | $20 |
| Sertraline | 20 | $289 | $14 |
| Furosemide | 23 | $212 | $9 |
| Sulfamethoxazole-Trimethoprim | 30 | $182 | $6 |
| Ciprofloxacin | 14 | $146 | $10 |
| Clonidine | 13 | $68 | $5 |
| Ibu | 13 | $56 | $4 |
2017: 59 drugs
| Januvia | 22 | $13,936 | $633 |
| Xarelto | 13 | $12,766 | $982 |
| Raloxifene | 40 | $7,638 | $191 |
| Symbicort | 16 | $7,553 | $472 |
| Bystolic | 14 | $6,857 | $490 |
| Levothyroxine | 182 | $5,123 | $28 |
| Rosuvastatin | 49 | $4,693 | $96 |
| Metformin Hcl Er | 53 | $3,331 | $63 |
| Atorvastatin | 136 | $3,071 | $23 |
| Metoprolol | 57 | $2,813 | $49 |
| Fenofibrate | 38 | $2,495 | $66 |
| Potassium Chloride | 30 | $1,900 | $63 |
| Creon | 13 | $1,667 | $128 |
| Lisinopril | 173 | $1,324 | $8 |
| Proair Hfa | 15 | $1,133 | $76 |
| Omeprazole | 41 | $1,107 | $27 |
| Metformin | 109 | $1,081 | $10 |
| Gabapentin | 53 | $1,054 | $20 |
| Synthroid | 24 | $921 | $38 |
| Ibandronate | 13 | $860 | $66 |
| Simvastatin | 122 | $849 | $7 |
| Ultra-Fine Nano Pen Needle | 13 | $782 | $60 |
| Losartan | 68 | $689 | $10 |
| Montelukast | 27 | $663 | $25 |
| Fluticasone Propionate | 36 | $658 | $18 |
| Alendronate | 54 | $627 | $12 |
| Valsartan | 11 | $626 | $57 |
| Citalopram Hbr | 44 | $598 | $14 |
| Amlodipine Besylate | 79 | $572 | $7 |
| Lovastatin | 32 | $560 | $17 |
| Pioglitazone | 31 | $553 | $18 |
| Pravastatin | 22 | $547 | $25 |
| Ranitidine | 23 | $545 | $24 |
| Carvedilol | 39 | $539 | $14 |
| Doxazosin Mesylate | 12 | $517 | $43 |
| Warfarin | 22 | $505 | $23 |
| Clarithromycin | 16 | $484 | $30 |
| Doxycycline Monohydrate | 23 | $395 | $17 |
| Clopidogrel | 24 | $390 | $16 |
| Allopurinol | 11 | $384 | $35 |
| Pantoprazole | 18 | $372 | $21 |
| Fluoxetine | 17 | $319 | $19 |
| Amoxicillin-Clavulanate Potass | 22 | $281 | $13 |
| Hydrochlorothiazide | 28 | $279 | $10 |
| Metoprolol | 26 | $265 | $10 |
| Trazodone | 18 | $264 | $15 |
| Oxybutynin Chloride | 12 | $250 | $21 |
| Sulfamethoxazole-Trimethoprim | 42 | $237 | $6 |
| Azithromycin | 33 | $236 | $7 |
| Furosemide | 30 | $221 | $7 |
| Glipizide Er | 14 | $213 | $15 |
| Gemfibrozil | 13 | $212 | $16 |
| Escitalopram | 20 | $210 | $10 |
| Glimepiride | 14 | $186 | $13 |
| Prednisone | 26 | $184 | $7 |
| Sertraline | 13 | $167 | $13 |
| Glipizide Xl | 12 | $161 | $13 |
| Ciprofloxacin | 14 | $153 | $11 |
| Atenolol | 12 | $117 | $10 |
2016: 56 drugs
| Januvia | 26 | $15,698 | $604 |
| Crestor | 21 | $10,654 | $507 |
| Raloxifene | 52 | $10,387 | $200 |
| Symbicort | 17 | $6,649 | $391 |
| Dexilant | 11 | $6,101 | $555 |
| Bystolic | 13 | $5,606 | $431 |
| Zetia | 11 | $5,153 | $468 |
| Levothyroxine | 171 | $4,297 | $25 |
| Atorvastatin | 107 | $2,378 | $22 |
| Omeprazole | 72 | $1,809 | $25 |
| Fenofibrate | 17 | $1,588 | $93 |
| Metoprolol | 34 | $1,547 | $45 |
| Creon | 13 | $1,278 | $98 |
| Ibandronate | 12 | $1,252 | $104 |
| Lisinopril | 136 | $1,186 | $9 |
| Proair Hfa | 13 | $1,066 | $82 |
| Metformin | 93 | $1,049 | $11 |
| Proventil Hfa | 12 | $897 | $75 |
| Simvastatin | 94 | $814 | $9 |
| Potassium Chloride | 15 | $810 | $54 |
| Acyclovir | 11 | $702 | $64 |
| Gabapentin | 29 | $608 | $21 |
| Pravastatin | 18 | $600 | $33 |
| Alendronate | 47 | $589 | $13 |
| Metformin Hcl Er | 58 | $585 | $10 |
| Metoprolol | 41 | $542 | $13 |
| Fluticasone Propionate | 20 | $531 | $27 |
| Citalopram Hbr | 27 | $526 | $19 |
| Clarithromycin | 16 | $500 | $31 |
| Amlodipine Besylate | 50 | $479 | $10 |
| Clopidogrel | 20 | $478 | $24 |
| Losartan | 44 | $460 | $10 |
| Doxazosin Mesylate | 11 | $454 | $41 |
| Lovastatin | 26 | $444 | $17 |
| Doxycycline Monohydrate | 16 | $420 | $26 |
| Pioglitazone | 16 | $346 | $22 |
| Carvedilol | 24 | $318 | $13 |
| Warfarin | 24 | $310 | $13 |
| Sertraline | 17 | $308 | $18 |
| Ciprofloxacin | 36 | $297 | $8 |
| Azithromycin | 29 | $290 | $10 |
| Trazodone | 24 | $289 | $12 |
| Methylprednisolone | 20 | $288 | $14 |
| Ranitidine | 15 | $259 | $17 |
| Montelukast | 12 | $237 | $20 |
| Hydrocodone-Acetaminophen | 20 | $221 | $11 |
| Hydrochlorothiazide | 32 | $196 | $6 |
| Fluoxetine | 17 | $172 | $10 |
| Mupirocin | 18 | $152 | $8 |
| Glipizide Xl | 15 | $151 | $10 |
| Ibuprofen | 14 | $142 | $10 |
| Oxycodone-Acetaminophen | 11 | $142 | $13 |
| Glipizide | 11 | $130 | $12 |
| Furosemide | 22 | $130 | $6 |
| Escitalopram | 14 | $126 | $9 |
| Sulfamethoxazole-Trimethoprim | 16 | $85 | $5 |
2015: 45 drugs
| Januvia | 12 | $9,803 | $817 |
| Raloxifene | 35 | $9,076 | $259 |
| Dexilant | 12 | $7,164 | $597 |
| Crestor | 15 | $7,118 | $475 |
| Symbicort | 13 | $6,541 | $503 |
| Bystolic | 13 | $5,865 | $451 |
| Vytorin | 15 | $5,100 | $340 |
| Evista | 13 | $3,316 | $255 |
| Levothyroxine | 128 | $3,172 | $25 |
| Atorvastatin | 85 | $2,271 | $27 |
| Proair Hfa | 15 | $1,739 | $116 |
| Metoprolol | 29 | $1,202 | $41 |
| Synthroid | 21 | $1,047 | $50 |
| Omeprazole | 56 | $1,005 | $18 |
| Gabapentin | 31 | $983 | $32 |
| Potassium Chloride | 17 | $925 | $54 |
| Lisinopril | 102 | $778 | $8 |
| Ranitidine | 16 | $719 | $45 |
| Citalopram Hbr | 17 | $713 | $42 |
| Clarithromycin | 22 | $699 | $32 |
| Metformin Hcl Er | 66 | $690 | $10 |
| Alendronate | 52 | $651 | $13 |
| Montelukast | 14 | $575 | $41 |
| Metformin | 65 | $571 | $9 |
| Losartan | 44 | $556 | $13 |
| Simvastatin | 64 | $526 | $8 |
| Tamsulosin | 13 | $506 | $39 |
| Fluticasone Propionate | 22 | $487 | $22 |
| Gemfibrozil | 19 | $433 | $23 |
| Hydrochlorothiazide | 32 | $426 | $13 |
| Warfarin | 23 | $417 | $18 |
| Amlodipine Besylate | 41 | $345 | $8 |
| Pioglitazone | 14 | $301 | $22 |
| Metoprolol | 27 | $299 | $11 |
| Mupirocin | 19 | $285 | $15 |
| Sertraline | 15 | $283 | $19 |
| Carvedilol | 28 | $273 | $10 |
| Ciprofloxacin | 43 | $262 | $6 |
| Trazodone | 23 | $207 | $9 |
| Fluoxetine | 12 | $185 | $15 |
| Triamterene-Hydrochlorothiazid | 15 | $179 | $12 |
| Sulfamethoxazole-Trimethoprim | 29 | $156 | $5 |
| Hydrocodone-Acetaminophen | 13 | $121 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $118 | $10 |
| Furosemide | 14 | $84 | $6 |
2014: 34 drugs
| Raloxifene | 21 | $6,437 | $307 |
| Crestor | 16 | $6,079 | $380 |
| Vytorin | 20 | $5,728 | $286 |
| Levothyroxine | 103 | $2,321 | $23 |
| Proair Hfa | 29 | $2,128 | $73 |
| Atorvastatin | 59 | $2,082 | $35 |
| Pioglitazone | 23 | $1,066 | $46 |
| Synthroid | 21 | $949 | $45 |
| Fluticasone Propionate | 20 | $932 | $47 |
| Pravastatin | 18 | $888 | $49 |
| Metoprolol | 26 | $884 | $34 |
| Lisinopril | 80 | $869 | $11 |
| Omeprazole | 39 | $851 | $22 |
| Clarithromycin | 18 | $746 | $41 |
| Simvastatin | 61 | $722 | $12 |
| Alendronate | 42 | $705 | $17 |
| Losartan | 26 | $699 | $27 |
| Metformin | 49 | $676 | $14 |
| Nitrofurantoin Mono-Macro | 13 | $659 | $51 |
| Gemfibrozil | 17 | $596 | $35 |
| Metformin Hcl Er | 44 | $585 | $13 |
| Gabapentin | 19 | $444 | $23 |
| Hydrochlorothiazide | 31 | $435 | $14 |
| Sertraline | 18 | $427 | $24 |
| Amlodipine Besylate | 33 | $414 | $13 |
| Warfarin | 29 | $397 | $14 |
| Ciprofloxacin | 51 | $354 | $7 |
| Carvedilol | 12 | $354 | $29 |
| Metoprolol | 23 | $241 | $10 |
| Trazodone | 11 | $172 | $16 |
| Azithromycin | 13 | $161 | $12 |
| Sulfamethoxazole-Trimethoprim | 20 | $115 | $6 |
| Hydrocodone-Acetaminophen | 13 | $111 | $9 |
| Atenolol | 12 | $103 | $9 |
2013: 22 drugs
| Evista | 17 | $6,621 | $389 |
| Pioglitazone | 22 | $3,167 | $144 |
| Atorvastatin | 36 | $1,742 | $48 |
| Omeprazole | 35 | $1,001 | $29 |
| Clarithromycin | 15 | $955 | $64 |
| Fluticasone Propionate | 22 | $762 | $35 |
| Levothyroxine | 36 | $717 | $20 |
| Synthroid | 12 | $592 | $49 |
| Metformin | 33 | $542 | $16 |
| Lovastatin | 15 | $511 | $34 |
| Losartan | 17 | $488 | $29 |
| Lisinopril | 49 | $460 | $9 |
| Metoprolol | 12 | $421 | $35 |
| Gabapentin | 16 | $418 | $26 |
| Metformin Hcl Er | 29 | $384 | $13 |
| Simvastatin | 29 | $376 | $13 |
| Alendronate | 18 | $335 | $19 |
| Metoprolol | 13 | $246 | $19 |
| Cefuroxime | 12 | $232 | $19 |
| Hydrochlorothiazide | 14 | $118 | $8 |
| Ciprofloxacin | 17 | $108 | $6 |
| Ibuprofen | 11 | $41 | $4 |
Money from drug and device companies
$132 in 2025
| 2025 | 2 | 2 | None | $132 |
| 2024 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $108 | 1 payment
|
| Pfizer | Paxlovid | $24 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-12-08 | Paxlovid | $24 |
| Inspire Medical Systems | Meals · 2025-10-16 | Inspire | $108 |
See earlier years (2024)
2024: $19
| Pfizer | Paxlovid | $19 | 1 payment
|
Professional record
- NPI
- 1255610630
- Licence
- AZ 4839, CA 57680California G57680: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2011-08-16
- NPI last updated
- 2025-03-17
- NPI record certified
- 2025-03-17
This is when the NPI record was last certified, not a medical board exam.